Variant report
Variant | esv3354884 |
---|---|
Chromosome Location | chr11:72961704-72964102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373772271 | chr11:72961708-72961709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555365793 | chr11:72961710-72961711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564408452 | chr11:72961715-72961716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367657212 | chr11:72961736-72961737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34635885 | chr11:72961741-72961742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550090633 | chr11:72961742-72961743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143508787 | chr11:72961752-72961753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531378723 | chr11:72961754-72961755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574539689 | chr11:72961770-72961771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529264487 | chr11:72961787-72961788 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372008544 | chr11:72961813-72961814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547937964 | chr11:72961830-72961831 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374831731 | chr11:72961851-72961852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568151226 | chr11:72961856-72961857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533940612 | chr11:72961874-72961875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372361663 | chr11:72961909-72961910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570686389 | chr11:72961947-72961948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs60610185 | chr11:72961980-72961981 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs556460014 | chr11:72962035-72962036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74645579 | chr11:72962091-72962092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188821756 | chr11:72962109-72962110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192260137 | chr11:72962142-72962143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182387914 | chr11:72962151-72962152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111219056 | chr11:72962272-72962273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186725596 | chr11:72962355-72962356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567243836 | chr11:72962418-72962419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576316034 | chr11:72962433-72962434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191278628 | chr11:72962514-72962515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184247715 | chr11:72962537-72962538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186991649 | chr11:72962545-72962546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535841891 | chr11:72962560-72962561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572226266 | chr11:72962561-72962562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371603516 | chr11:72962649-72962650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374406981 | chr11:72962668-72962669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541165216 | chr11:72962675-72962676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369115294 | chr11:72962682-72962683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368280116 | chr11:72962690-72962691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371704522 | chr11:72962692-72962693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372394064 | chr11:72962693-72962694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376767880 | chr11:72962697-72962698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374935888 | chr11:72962699-72962700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371649376 | chr11:72962702-72962703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557910938 | chr11:72962703-72962704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369649933 | chr11:72962709-72962710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373004548 | chr11:72962719-72962720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376393598 | chr11:72962723-72962724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377502110 | chr11:72962724-72962725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369807179 | chr11:72962726-72962727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373292335 | chr11:72962729-72962730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373113501 | chr11:72962736-72962737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 19153074 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:72953000-72962000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr11:72954000-72963600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr11:72954200-72964000 | Weak transcription | Duodenum Mucosa | Duodenum |
4 | chr11:72954200-72968600 | Weak transcription | Left Ventricle | heart |
5 | chr11:72954400-72967000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr11:72955800-72962000 | Enhancers | Placenta | Placenta |
7 | chr11:72956200-72963800 | Weak transcription | Fetal Heart | heart |
8 | chr11:72956600-72968600 | Weak transcription | Lung | lung |
9 | chr11:72959600-72961800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr11:72960000-72962000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr11:72960400-72961800 | Enhancers | GM12878-XiMat | blood |
12 | chr11:72960800-72961800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr11:72960800-72975400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
14 | chr11:72961200-72963600 | Weak transcription | A549 | lung |
15 | chr11:72961200-72968400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
16 | chr11:72961800-72963600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr11:72962000-72966800 | Weak transcription | Placenta | Placenta |
18 | chr11:72963600-72963800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr11:72963600-72964000 | Active TSS | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr11:72963600-72964200 | Enhancers | A549 | lung |
21 | chr11:72963800-72964000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
22 | chr11:72963800-72964200 | Enhancers | Fetal Heart | heart |
23 | chr11:72964000-72964200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
24 | chr11:72964000-72964200 | Enhancers | Duodenum Mucosa | Duodenum |
25 | chr11:72964000-72968000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |